Xenon Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Go back to Xenon Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
(NASDAQ: XENE) Delayed: 59.89 +0.14 (0.23%)
Previous Close $59.75    52 Week High $9.75 
Open $58.95    52 Week Low $5.65 
Day High $60.36    P/E N/A 
Day Low $58.27    EPS $0.00 
Volume 413,169